Therapeutic options for pulmonary edema associated with nuclear factor-kappaB activation in septicemia.
Eisenhut
Michael
M
D000818:Animals; D006239:Haplotypes; D006801:Humans; D053592:Interleukin-1 Receptor-Associated Kinases; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D051379:Mice; D016328:NF-kappa B / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D011654:Pulmonary Edema / Q000628:therapy*; D017472:Receptors, Interleukin-1 / Q000235:genetics*; D012121:Respiration, Artificial; D012128:Respiratory Distress Syndrome / Q000235:genetics; D018805:Sepsis / Q000235:genetics*; D014178:Translocation, Genetic
D047908:Intracellular Signaling Peptides and Proteins; D016328:NF-kappa B; D017472:Receptors, Interleukin-1; D053592:Interleukin-1 Receptor-Associated Kinases; D017346:Protein Serine-Threonine Kinases